HLA Class II Genotyping of African American Type 1 Diabetic Patients Reveals Associations Unique to African Haplotypes
Open Access
- 15 August 2013
- journal article
- Published by American Diabetes Association in Diabetes
- Vol. 62 (9) , 3292-3299
Abstract
HLA genotyping was performed in African American type 1 diabetic patients (n = 772) and controls (n = 1,641) in the largest study of African Americans and type 1 diabetes reported to date. Cases were from Children’s Hospital and Research Center Oakland and from existing collections (Type 1 Diabetes Genetics Consortium [T1DGC], Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications [DCCT/EDIC], and Genetics of Kidneys in Diabetes [GoKinD]). Controls were from the T1DGC and from newborn bloodspot cards. The diversity of HLA DRB1-DQA1-DQB1 haplotypes and genotypes is far greater than that found in Europeans and European Americans. Association analyses replicated many type 1 diabetes risk effects of European-derived haplotypes but also revealed novel effects for African-derived haplotypes. Notably, the African-specific “DR3” haplotype DRB1*03:02-DQA1*04:01-DQB1*04:02 is protective for type 1 diabetes, in contrast to the common and highly-susceptible DR3 DRB1*03:01-DQA1*05:01-DQB1*02:01. Both DRB1*07:01 and DRB1*13:03 haplotypes are predisposing when they include DQA1*03:01-DQB1*02:01g but are protective with DQA1*02:01-DQB1*02:01g. The heterozygous DR4/DR9 genotype, containing the African-derived “DR9” haplotype DRB1*09:01-DQA1*03:01-DQB1*02:01g, exhibits extremely high risk (odds ratio = 30.88), approaching that for DR3/DR4 in European populations. Disease risk assessment for African Americans differs greatly from risk assessment in European populations. This has profound implications on risk screening programs and underscores the need for high-resolution genotyping of multiple populations for the rational design of screening programs with tests that will fairly represent the population being screened.Keywords
This publication has 19 references indexed in Scilit:
- Epidemiology of Type 1 DiabetesEndocrinology and Metabolism Clinics of North America, 2010
- HLA genotyping in the international Type 1 Diabetes Genetics ConsortiumClinical Trials, 2010
- Insights to the Genetics of Diabetic Nephropathy Through a Genome-Wide Association Study of the GoKinD CollectionSeminars in Nephrology, 2010
- Diabetes in African American YouthDiabetes Care, 2009
- HLA DR-DQ Haplotypes and Genotypes and Type 1 Diabetes RiskDiabetes, 2008
- Diabetes Health DisparitiesMedical Care Research and Review, 2007
- The Type 1 Diabetes Genetics ConsortiumAnnals of the New York Academy of Sciences, 2006
- Diabetic nephropathy in African-American patientsCurrent Diabetes Reports, 2004
- Dose Effect of Cis- and Trans-Encoded HLA-DQαβ Heterodimers in IDDM SusceptibilityDiabetes, 1992
- MHC Class-II Molecules and AutoimmunityAnnual Review of Immunology, 1991